| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-1843 | |
| Phytochemical name or plant extracts | 2α,3β-dihydroxy-urs-20(30)-en-28-oic acid | |
| PMID | 25088972 | |
| Literature evidence | Among the triterpenoids isolated, 2α,3β,19α-trihydroxy-urs-12-en-28-oic acid (7), 9 and 10 showed high potent inhibitory activity toward the proliferation of HepG2 cells, which the IC50 values were lower than 5 μM. | |
| IUPAC name | (1S,4aS,6aR,6bR,10R,11R,12aR,14aR)-10,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-docosahydropicene-4a-carboxylic acid | |
| Phytochemicals’ class or type of plant extracts | Triterpenoid | |
| Source of phytochemicals or plant Extracts | Sour jujube | |
| Geographical availability | NA | |
| Plant parts | NA | |
| Other cancers | Breast cancer, Liver cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | 0.8 ± 0.03 μM against MCF-7 | |
| Potency | NA | |
| Cell line/ mice model | HepG2, MCF-7 | |
| Additional information | NA | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | NA | |
| Safety | NA |